Bio Green Med Solution, Inc. — Director's Dealing 2009

Oct 5, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2009-10-01

Reporting Person: MORGAN STANLEY (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-01	Common Stock	P	57200	$0.90	Acquired	2837224	Indirect
2009-10-01	Common Stock	S	57200	$0.90	Disposed	2780024	Indirect

Footnotes

F1: The reported securities are held directly by certain funds (each, a "Fund" and collectively, the "Funds") managed by indirect
subsidiary entities of the reporting person. FrontPoint Partners LLC ("FPP"), an indirect wholly owned subsidiary of the
reporting person is the parent company of each entity that is the investment manager of one or more of the Funds. This form
is filed without prejudice to the reporting person's position that none of the Funds nor FPP or any of its subsidiaries, nor
the reporting person, individually or in aggregate, are required to file beneficial ownership reports under Section 16(a) of
the Securities Exchange Act of 1934, and should not be construed or interpreted as a concession or admission that such
reports are required.